ask="2.75"
ask_size="100"
average_daily_volume="351750"
bid="1.95"
bid_size="400"
book_value="0.88"
change="-0.03"
change_from_200_day_moving_average="-1.92"
change_from_50_day_moving_average="-0.25"
change_from_52_week_high="-4.93"
change_From_52_week_low="0.23"
change_in_percent="-1.23%"
close="2.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.11"
ex_dividend_date="N/A"
float_shares="25714000"
high="2.03"
high_52_weeks="6.93"
last_trade_date="1/27/2017"
last_trade_price="2.00"
last_trade_size="7357"
last_trade_time="4:00pm"
low="1.90"
low_52_weeks="1.77"
market_capitalization="61.23M"
moving_average_200_day="3.92"
moving_average_50_day="2.25"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="2.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-48.98%"
percent_change_from_50_day_moving_average="-11.21%"
percent_change_from_52_week_high="-71.14%"
percent_change_from_52_week_low="+12.68%"
previous_close="2.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.31"
price_per_sales="158.08"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="4.56"
stock_exchange="NCM"
symbol="TROV"
volume="251700"
weeks_range_52="1.77 - 6.93"
